Vipin Garg, based in Gaithersburg, MD, US, is currently a President, CEO and Board Director at Altimmune, Inc. (NASDAQ: ALT), bringing experience from previous roles at Altimmune, Neos Therapeutics, Tranzyme Pharma and Apex Bioscience. Vipin Garg holds a 1983 - 1984 Drexel. With a robust skill set that includes Clinical Trials, CNS disorders, Metabolic Disorders, CRO, Cell Biology and more, Vipin Garg contributes valuable insights to the industry. Vipin Garg has 3 emails on RocketReach.